Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Sep-24 7:18 PM View:  | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Bioxcel Therapeutics, Inc. (BTAI) | 16-Sep-24 | Planned Option Sale | 215 | $0.69 | $148.52 | (5%) 4.25K to 4.03K | |
| 17-Sep-24 7:21 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 16-Sep-24 | Planned Option Sale | 356 | $0.69 | $245.60 | (5%) 6.56K to 6.2K | |
| 17-Sep-24 7:20 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 16-Sep-24 | Planned Option Sale | 345 | $0.69 | $238.05 | (4%) 9.48K to 9.13K | |
| 17-Sep-24 7:21 PM View: | Mehta Vimal CEO and President Director 10% Owner | Bioxcel Therapeutics, Inc. (BTAI) | 16-Sep-24 | Planned Option Sale | 1,982 | $0.69 | $1,366.91 | (< 1%) 7.74M to 7.74M | |
| 17-Sep-24 7:23 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 16-Sep-24 | Planned Option Sale | 355 | $0.69 | $244.70 | (2%) 14.56K to 14.2K | |
| 17-Sep-24 7:19 PM View: | O'Neill Vincent See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 16-Sep-24 | Planned Option Sale | 138 | $0.69 | $95.33 | (3%) 4.04K to 3.91K | |
| 17-Sep-24 7:21 PM View: | Mehta Vimal CEO and President Director 10% Owner | Bioxcel Therapeutics, Inc. (BTAI) | 15-Sep-24 | Option Exercise | 3,500 | -- | -- | < 1% 7.74M to 7.74M | |
| 17-Sep-24 7:23 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 15-Sep-24 | Option Exercise | 563 | -- | -- | 4% 13.99K to 14.56K | |
| 17-Sep-24 7:18 PM View: | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Bioxcel Therapeutics, Inc. (BTAI) | 15-Sep-24 | Option Exercise | 750 | -- | -- | 21% 3.5K to 4.25K | |
| 17-Sep-24 7:21 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 15-Sep-24 | Option Exercise | 563 | -- | -- | 9% 6.0K to 6.56K | |
| 17-Sep-24 7:20 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 15-Sep-24 | Option Exercise | 563 | -- | -- | 6% 8.91K to 9.48K | |
| 17-Sep-24 7:23 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-24 | Option Exercise | 521 | -- | -- | 4% 13.47K to 13.99K | |
| 17-Sep-24 7:21 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-24 | Option Exercise | 521 | -- | -- | 10% 5.48K to 6.0K | |
| 17-Sep-24 7:19 PM View: | O'Neill Vincent See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-24 | Option Exercise | 521 | -- | -- | 15% 3.52K to 4.04K | |
| 17-Sep-24 7:20 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-24 | Option Exercise | 521 | -- | -- | 6% 8.39K to 8.91K | |
| 17-Sep-24 7:21 PM View: | Mehta Vimal CEO and President Director 10% Owner | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-24 | Option Exercise | 2,609 | -- | -- | < 1% 7.74M to 7.74M | |
| 06-Jun-24 8:35 PM View: | Mehta Vimal CEO and President Director 10% Owner | Bioxcel Therapeutics, Inc. (BTAI) | 05-Jun-24 | Sale | 409,136 | $0.49 | $199,619.00 | (5%) 8.14M to 7.73M | |
| 06-Jun-24 8:35 PM View: | Mehta Vimal CEO and President Director 10% Owner | Bioxcel Therapeutics, Inc. (BTAI) | 04-Jun-24 | Sale | 1,018,360 | $0.20 | $205,516.00 | (11%) 9.16M to 8.14M | |
| 08-Apr-24 7:32 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 5,268 | $2.62 | $13,823.00 | (< 1%) 8.6M to 8.59M | |
| 08-Apr-24 7:32 PM View: | O'Neill Vincent See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 165 | $2.62 | $432.48 | (3%) 5.57K to 5.41K | |
| 08-Apr-24 7:30 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 1,012 | $2.64 | $2,667.43 | (12%) 8.68K to 7.67K | |
| 08-Apr-24 7:31 PM View: | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 1,008 | $2.64 | $2,656.18 | (25%) 4.0K to 2.99K | |
| 08-Apr-24 7:30 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 1,067 | $2.63 | $2,811.54 | (4%) 27.66K to 26.59K | |
| 08-Apr-24 7:32 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 1,069 | $2.63 | $2,816.81 | (18%) 5.83K to 4.76K | |
| 08-Apr-24 7:30 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 2,250 | -- | -- | 9% 25.41K to 27.66K | |
| 08-Apr-24 7:32 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 2,250 | -- | -- | 63% 3.58K to 5.83K | |
| 08-Apr-24 7:32 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 14,000 | -- | -- | < 1% 8.58M to 8.6M | |
| 08-Apr-24 7:32 PM View: | O'Neill Vincent See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 2,250 | -- | -- | 68% 3.32K to 5.57K | |
| 08-Apr-24 7:30 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 2,250 | -- | -- | 35% 6.43K to 8.68K | |
| 08-Apr-24 7:31 PM View: | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 08-Apr-24 7:30 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-24 | Option Exercise | 521 | -- | -- | 2% 24.89K to 25.41K | |
| 08-Apr-24 7:32 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-24 | Option Exercise | 521 | -- | -- | 17% 3.06K to 3.58K | |
| 08-Apr-24 7:32 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-24 | Option Exercise | 2,610 | -- | -- | < 1% 8.58M to 8.58M | |
| 08-Apr-24 7:32 PM View: | O'Neill Vincent See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-24 | Option Exercise | 521 | -- | -- | 19% 2.8K to 3.32K | |
| 08-Apr-24 7:30 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-24 | Option Exercise | 521 | -- | -- | 9% 5.91K to 6.43K | |
| 18-Dec-23 4:55 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 14-Dec-23 | Option Exercise | 2,609 | -- | -- | < 1% 8.58M to 8.58M | |
| 18-Dec-23 4:54 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-Dec-23 | Option Exercise | 521 | -- | -- | 10% 5.39K to 5.91K | |
| 18-Dec-23 4:47 PM View: | O'Neill Vincent Chief Medical Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Dec-23 | Option Exercise | 521 | -- | -- | 23% 2.28K to 2.8K | |
| 18-Dec-23 4:57 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Dec-23 | Option Exercise | 521 | -- | -- | 5% 10.54K to 11.06K | |
| 18-Dec-23 4:52 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Dec-23 | Option Exercise | 521 | -- | -- | 20% 2.54K to 3.06K | |
| 18-Sep-23 4:48 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-23 | Option Exercise | 521 | -- | -- | 11% 4.87K to 5.39K | |
| 18-Sep-23 4:47 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-23 | Option Exercise | 2,610 | -- | -- | 9% 29.0K to 31.61K | |
| 18-Sep-23 4:47 PM View: | O'Neill Vincent Chief Medical Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-23 | Option Exercise | 521 | -- | -- | 30% 1.76K to 2.28K | |
| 18-Sep-23 4:49 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-23 | Option Exercise | 521 | -- | -- | 5% 10.02K to 10.54K | |
| 18-Sep-23 4:49 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-23 | Option Exercise | 521 | -- | -- | 26% 2.02K to 2.54K | |
| 24-May-23 4:37 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 22-May-23 | Private Sale (Planned) | 6,500 | $25.79 | $167,641.00 | (14%) 45.79K to 39.29K | |
| 16-May-23 8:32 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 15-May-23 | Planned Option Sale | 5,000 | $27.17 | $135,864.00 | (77%) 6.5K to 1.5K | |
| 16-May-23 8:29 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 15-May-23 | Planned Option Sale | 1,785 | $27.32 | $48,764.80 | (29%) 6.13K to 4.35K | |
| 16-May-23 8:33 PM View: | Mehta Vimal CEO and President | Bioxcel Therapeutics, Inc. (BTAI) | 14-May-23 | Option Exercise | 15,000 | -- | -- | 84% 17.89K to 32.89K | |
| 16-May-23 8:32 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-May-23 | Option Exercise | 5,000 | -- | -- | 333% 1.5K to 6.5K |
